Eric Triau

¹⁸F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

Rik Vandenberghe, Koen Van Laere, Adrian Ivanoiu et al. · Annals of Neurology · 2010 · 644 citations

Medicine, Neurology, Nuclear Medicine +17

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

Alistair Burns, Roberto Bernabei, Roger Bullock et al. · The Lancet Neurology · 2008 · 152 citations

Medicine, Neurology, Pharmacology +14

In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment

Heleen Vanhaute, Jenny Ceccarini, Laura Michiels et al. · Neurology · 2020 · 94 citations

Life Sciences, Neurology, Neuroscience +17

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment

David A. Wolk, Carl Sadowsky, Beth Safirstein et al. · JAMA Neurology · 2018 · 87 citations · Full text

Medicine, Neurology, Neuroscience +17

Spatial decrease of synaptic density in amnestic mild cognitive impairment follows the tau build-up pattern

Greet Vanderlinden, Jenny Ceccarini, Thomas Vande Casteele et al. · Molecular Psychiatry · 2022 · 48 citations · Full text

Life Sciences, Neurology, Neuroscience +17